Pharmaceuticals and Medical Devices: Cost Savings

Issue Brief Health Policy Track Serv. 2018 Dec 24:2018:1-31.
No abstract available

MeSH terms

  • Anti-Retroviral Agents / economics
  • Canada
  • Cost Control
  • Cost Savings*
  • Drug Approval / economics
  • Drug Approval / legislation & jurisprudence
  • Drug Costs*
  • Drug Industry / economics
  • Drug Industry / legislation & jurisprudence
  • Drugs, Generic / economics
  • Economics, Pharmaceutical*
  • Health Benefit Plans, Employee
  • Humans
  • Legislation, Drug*
  • Medication Adherence
  • Prescription Drugs / economics*
  • State Government
  • United States

Substances

  • Anti-Retroviral Agents
  • Drugs, Generic
  • Prescription Drugs